富血小板血浆市场：按来源类型（同种异体、自体、同种异体）、按应用 - 俄乌衝突和高通货膨胀 - 2023-2030 年全球预测

预计2023年全球富血小板血浆市场将达到3.8163亿美元，复合年增长率为12.34%，大幅增长，2030年将达到8.4854亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球富血小板血浆市场至关重要。 通过检查业务战略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的具体需求做出明智的决策。 这种高级分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市场份额分析

市场份额分析可以深入了解供应商在特定市场区域的当前状态。 比较供应商对整体收入、客户群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。 该分析还揭示了特定行业的竞争程度、积累和分散的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要公司所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场领域的渗透率。

3. 市场多元化：提供有关新产品发布、未开发地区、最新开发和投资的详细资讯。

4.市场趋势：全面了解俄罗斯-乌克兰衝突和高通胀。

5.竞争评估和资讯：对主要公司的市场份额、战略、产品、认证、监管状况、专利状况、製造能力进行综合评估。

6. 产品开发和创新：提供对未来技术、研发活动和突破性产品开发的见解。

此报告回答了以下问题：

1.富血小板血浆的全球市场规模和预测是多少？

2. 在预测期内，COVID-19 对全球富血小板血浆市场的影响有哪些抑制因素和影响？

3. 在预测期内，全球富血小板血浆市场需要投资哪些产品/细分市场/应用/领域？

4. 你们在全球富血小板血浆市场上的竞争策略是什么？

5.全球富血小板血浆市场的技术趋势和监管框架是什么？

6.全球富血小板血浆市场主要厂商的市场份额如何？

7. 哪些形式和战略举措被认为适合进入富血小板血浆全球市场？

目录

第 1 章前言

第 2 章研究方法

第 3 章执行摘要

第 4 章市场概述

第 5 章市场洞察

• 市场动态
  • 促进因素
    • 全球范围内运动相关伤害的发生率正在上升
    • 在肌肉骨骼和骨科疾病治疗中的可能应用
    • 越来越多地在整容手术和自然癒合过程中使用
  • 抑制因素
    • 血小板血浆治疗效果的不确定性
  • 机会
    • 再生医学的新应用
    • 对富含血小板血浆的生物活性分子进行持续的研发活动
  • 课题
    • 富含血小板血浆产品的临床试验和报销政策的供应有限
• 市场趋势
• 新冠肺炎 (COVID-19) 的累积影响
• 俄罗斯-乌克兰衝突的累积影响
• 高通胀的累积影响
• 波特五力分析
• 价值炼和关键路径分析
• 监管框架
• 客户定制

第 6 章按来源类型划分的富血小板血浆市场

• 同种异体
• 自体来源
• 同源

第 7 章富血小板血浆市场：按应用分类

• 整容手术
• 普通外科
• 神经外科
• 骨科

第 8 章美洲富血小板血浆市场

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第 9 章亚太地区富血小板血浆市场

• 澳大利亚
• 中国
• 印度
• 印度尼西亚
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第 10 章欧洲、中东和非洲的富血小板血浆市场

• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 意大利
• 荷兰
• 尼日利亚
• 挪威
• 波兰
• 卡塔尔
• 俄罗斯
• 沙特阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯联合酋长国
• 英国

第 11 章竞争态势

• FPNV定位矩阵
• 市场份额分析：主要公司
• 竞争情景分析：主要公司

第 12 章上市公司名单

第 13 章附录

• 讨论指南
• 关于许可证和价格

The Global Platelet Rich Plasma Market is forecasted to grow significantly, with a projected USD 381.63 million in 2023 at a CAGR of 12.34% and expected to reach a staggering USD 848.54 million by 2030.

The the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Platelet Rich Plasma Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Platelet Rich Plasma Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Source Type, market is studied across Allogenic, Autologous, and Homologous. The Autologous commanded largest market share of 44.31% in 2022, followed by Homologous.

Based on Application, market is studied across Cosmetic Surgery, General Surgery, Neurosurgery, and Orthopedic Surgery. The General Surgery commanded largest market share of 22.35% in 2022, followed by Neurosurgery.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 39.64% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Platelet Rich Plasma Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Platelet Rich Plasma Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Platelet Rich Plasma Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Platelet Rich Plasma Market?

4. What is the competitive strategic window for opportunities in the Global Platelet Rich Plasma Market?

5. What are the technology trends and regulatory frameworks in the Global Platelet Rich Plasma Market?

6. What is the market share of the leading vendors in the Global Platelet Rich Plasma Market?

7. What modes and strategic moves are considered suitable for entering the Global Platelet Rich Plasma Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Platelet Rich Plasma Market, by Source Type, 2022 vs 2030
• 4.3. Platelet Rich Plasma Market, by Application, 2022 vs 2030
• 4.4. Platelet Rich Plasma Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing Incidences of Sports-Related Injuries Globally
    • 5.1.1.2. Potential Application in the Treatment of Musculoskeletal Conditions and Orthopedic Disorders
    • 5.1.1.3. Increasing Use in Cosmetic Surgery and for Natural Healing Process
  • 5.1.2. Restraints
    • 5.1.2.1. Uncertainty on Therapeutic Efficacy of Platelet Rich Plasma
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging Application in Regenerative Medicine
    • 5.1.3.2. Ongoing Research and Development Activities on Platelet-Rich Plasma Derived Bioactive Molecules
  • 5.1.4. Challenges
    • 5.1.4.1. Limited Availability of Clinical Trials and Reimbursement Policies of Platelet-rich Plasma Products
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Platelet Rich Plasma Market, by Source Type

• 6.1. Introduction
• 6.2. Allogenic
• 6.3. Autologous
• 6.4. Homologous

7. Platelet Rich Plasma Market, by Application

• 7.1. Introduction
• 7.2. Cosmetic Surgery
• 7.3. General Surgery
• 7.4. Neurosurgery
• 7.5. Orthopedic Surgery

8. Americas Platelet Rich Plasma Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Platelet Rich Plasma Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Platelet Rich Plasma Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
• 11.2. Market Share Analysis, By Key Player
• 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing

1. APEX Biologix, LLC

2. Arthrex, Inc.

3. Biotest AG

4. Celling Biosciences, Inc.

5. China Biologic Products Holdings, Inc.

6. CSL Limited

7. Dr PRP USA LLC

8. Eclipse

9. EmCyte Corporation

10. Estar Technologies Ltd.

11. Exactech, Inc.

12. Glofinn Oy

13. Johnson & Johnson

14. Juventix Regenerative Medical, LLC

15. Stryker Corporation

16. Terumo BCT, Inc.

17. ThermoGenesis Holdings, Inc.

18. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

• FIGURE 1. PLATELET RICH PLASMA MARKET RESEARCH PROCESS
• FIGURE 2. PLATELET RICH PLASMA MARKET SIZE, 2022 VS 2030
• FIGURE 3. PLATELET RICH PLASMA MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2022 VS 2030 (%)
• FIGURE 5. PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 6. PLATELET RICH PLASMA MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 7. PLATELET RICH PLASMA MARKET DYNAMICS
• FIGURE 8. PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 9. PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. PLATELET RICH PLASMA MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 15. PLATELET RICH PLASMA MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. PLATELET RICH PLASMA MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. PLATELET RICH PLASMA MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 5. PLATELET RICH PLASMA MARKET SIZE, BY ALLOGENIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. PLATELET RICH PLASMA MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. PLATELET RICH PLASMA MARKET SIZE, BY HOMOLOGOUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 9. PLATELET RICH PLASMA MARKET SIZE, BY COSMETIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. PLATELET RICH PLASMA MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. PLATELET RICH PLASMA MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. PLATELET RICH PLASMA MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 16. ARGENTINA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 17. ARGENTINA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 18. BRAZIL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 19. BRAZIL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. CANADA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 21. CANADA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. MEXICO PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 23. MEXICO PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. AUSTRALIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 31. AUSTRALIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. CHINA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 33. CHINA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. INDIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 35. INDIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. INDONESIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 37. INDONESIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. JAPAN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 39. JAPAN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. MALAYSIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 41. MALAYSIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. PHILIPPINES PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 43. PHILIPPINES PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. SINGAPORE PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 45. SINGAPORE PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. SOUTH KOREA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 47. SOUTH KOREA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. TAIWAN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 49. TAIWAN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. THAILAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 51. THAILAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. VIETNAM PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 53. VIETNAM PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. DENMARK PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 58. DENMARK PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. EGYPT PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 60. EGYPT PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. FINLAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 62. FINLAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. FRANCE PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 64. FRANCE PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. GERMANY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 66. GERMANY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. ISRAEL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 68. ISRAEL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. ITALY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 70. ITALY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. NETHERLANDS PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 72. NETHERLANDS PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. NIGERIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 74. NIGERIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. NORWAY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 76. NORWAY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. POLAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 78. POLAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. QATAR PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 80. QATAR PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. RUSSIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 82. RUSSIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. SAUDI ARABIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 84. SAUDI ARABIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH AFRICA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH AFRICA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. SPAIN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 88. SPAIN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. SWEDEN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 90. SWEDEN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. SWITZERLAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 92. SWITZERLAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. TURKEY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 94. TURKEY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. UNITED ARAB EMIRATES PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 96. UNITED ARAB EMIRATES PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. UNITED KINGDOM PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
• TABLE 98. UNITED KINGDOM PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. PLATELET RICH PLASMA MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 100. PLATELET RICH PLASMA MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 101. PLATELET RICH PLASMA MARKET LICENSE & PRICING